ID: ALA3627769

Max Phase: Preclinical

Molecular Formula: C18H18ClN5O

Molecular Weight: 319.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.N=C(N)N1CC[C@H]1c1nc(-c2ccc(-c3ccccc3)cc2)no1

Standard InChI:  InChI=1S/C18H17N5O.ClH/c19-18(20)23-11-10-15(23)17-21-16(22-24-17)14-8-6-13(7-9-14)12-4-2-1-3-5-12;/h1-9,15H,10-11H2,(H3,19,20);1H/t15-;/m0./s1

Standard InChI Key:  IUXXOOGURMVRHT-RSAXXLAASA-N

Associated Targets(Human)

Sphingosine kinase 1 1990 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sphingosine kinase 2 214 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 319.37Molecular Weight (Monoisotopic): 319.1433AlogP: 3.04#Rotatable Bonds: 3
Polar Surface Area: 92.03Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 11.12CX LogP: 3.55CX LogD: 1.09
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.57Np Likeness Score: -1.09

References

1. Congdon MD, Childress ES, Patwardhan NN, Gumkowski J, Morris EA, Kharel Y, Lynch KR, Santos WL..  (2015)  Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.,  25  (21): [PMID:25862200] [10.1016/j.bmcl.2015.03.041]

Source